Economising vein-graft surveillance programs  by Idu, M.M. et al.
Eur J Vasc Endovasc Surg 15, 432-438 (1998) 
Economising Vein-graft Surveillance Programs 
M. M. Idu% J. Buth% Ph. Cuypers% W. C. J. Hop 2, E. D. W, M. van de Pavoordt a 
and J. M, H, Tordoir 4 
1Departments of Surgery of the Catharina Hospital Eindhoven, ZDepartment of Epidemiology and Statistics, Erasmus 
University Rotterdam, 3Sint Antonius Hospital Nieuwegein and 4The University Hospital Maastricht, The 
Netherlands 
Objectives: To investigate the effectiveness of two alternative vein-graft surveillance strategies. In the first strategy 
surveillance was restricted to patients with a possible higher risk of significant stenosis development, i.e. those with a 
moderate stenosis identified early after the operation. In the second strategy the effects of reducing the number of duplex 
tests per patient was examined. 
Patients and Methods: In a prospective study in three vascular surgical departments 300 patients (300 femoropopliteal 
or distal grafts) underwent duplex surveillance during the first year after the operation. The duplex-derived PSV-ratio 
was considered to represent he degree of stenosis. Arteriographic confirmation of suspected stenoses was routinely 
obtained, and patients without a suspected graft stenosis underwent a consented arteriogram during the first postoperative 
year. The decision to petform ag'aft revision was taken on the basis of an arteriographic stenosis of at least 70% diameter 
reduction. In the fi'rst strategy graft categories were defined on the basis of the first postoperative duplex examination: 
grafts with a PSV-ratio <1.5, grafts with a PSV-ratio <1.5-2.0, grafts with a PSV-ratio of 2.0-2.5, grafts with PSV- 
ratios 2.5-3.0, and grafts with PSV-ratios >3.0. The primary patency rate at 12 months was compared for these categories. 
In the second alternative strategy the number of examinations and the percentage of event causing de novo stenoses 
were analysed per surveillance interval. 
Results: The presence of moderate abnormalities at the initial duplex scan did not identify patients with a high risk of 
an event, as initial PSV-ratios of 1.5-2.0 and 2.0-2.5 (early mild-moderate l sions) had comparable 12-month primary 
patencies to patients with a PSV-ratio <1.5 (completely normal grafts): (63%, 73%, and 71%, respectively). The interval 
incidence of event causing de novo stenoses was 8% of the total number of duplex tests petformed at 3 months, and 8% 
at 6 months after the operation. In patients who had no previous intervention for stenosis and had a normal bypass 
during the first 6 months postoperatively, a sharp drop in this incidence was seen at 9 and 12 months, with event causing 
de novo stenoses observed in only 2% and 1% of all duplex tests. 
Conclusions: All patients hould be included in a surveillance program, as the presence of a normal vein graft at the 
first duplex examination does not rule out the subsequent development of graft stenosis. The duration of the surveillance 
period may be restricted to the first 6 months after operation in patients who have a normal bypass during that time 
period, as only few stenoses will be missed by this policy. 
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Introduction 
Intrinsic vein-graft stenosis is a major threat to infra- 
inguinal bypasses. In approximately 30% of all vein 
grafts, stenotic lesions will develop, due to intima 
hyperplasia, remodelling or fibrosis. 13 Vein-graft sur- 
veillance has been shown to be an effective method 
of identifying stenotic lesions, thus allowing repair of 
these defects before graft thrombosis occurs. However, 
the necessity for repetitive duplex testing during a 
longer period of time makes considerable demands 
on patients and vascular laboratories. Better utilisation 
* Please address all reprint requests and correspondence to:J. Buth, 
Department ofSurgery, Catharina Hospital, P.O. Box 1350, 5602 ZA 
Eirtdhoven, The Netherlands. 
of resources may be obtained by restricting sur- 
veillance testing to patients at high risk of developing 
graft stenosis. Several patient factors, operative tech- 
nical and vein-graft related factors have been identified 
as being associated with an increased risk of stenosis 
development or graft occlusion. 4'5 Recently it has been 
suggested that most stenotic lesions are the result of 
progression of residual vein-graft lesions or platelet 
deposits already present at the time of operation. In 
this view it might be possible that patients with grafts 
that have a high risk of developing significant lesions 
during follow-up can be identified by the first post- 
operative duplex scanning soon after the bypass pro- 
cedure. 6-8 
The large majority of graft lesions develop within 
the first 12 months, and many authors agree, therefore, 
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that surveillance may be discontinued at that time. 4'9 
Others have stressed that serial examinations cannot 
be dispensed after i year and graft surveillance should 
be continued for longer periods, if not for the duration 
of the patient's life. 1°-13 An alternative way of reducing 
expenses and workload involved with stenosis de- 
tection may be to limit the duration of the surveillance 
period and thus the number of examinations. 
In this study the effectiveness of these two strategies 
targeted to a reduction of duplex surveillance testing 
was investigated. The first strategy attempted to re- 
duce the number of patients for continued surveillance 
by identifying rafts with a higher risk of significant 
stenosis, indicated by the presence of early duplex 
abnormalities. In the second strategy, the effect of 
reducing the duration of the surveillance program in 
the overall patient group, with regard to the number 
of graft stenoses that would be missed, was examined. 
Patients and Methods 
From June 1993 to September 1995, 346 patients under- 
went infrainguinal bypass grafting and enrolled in a 
prospective follow-up study that involved a carefully 
monitored surveillance program. This study was a 
combined effort of three vascular surgical de- 
partments: the University Hospital Maastricht, Sint 
Antonius Hospital Nieuwegein, and Catharina Hos- 
pital Eindhoven. All centres had a well-equipped and 
staffed clinical vascular laboratory. 
The preoperative workup consisted of a pre- 
operative angiogram. Duplex assessment of the greater 
saphenous vein was performed if there was doubt 
about its suitability. A variety of operative techniques 
was used to perform the bypass procedures. In situ 
saphenous vein grafts was the preferred method if 
there was a suitable ipsilateral saphenous vein avail- 
able. Ectopic veins were used, either in a reversed or 
in a non-reversed fashion depending on the vein taper 
and the optimal size match between vein graft, inflow 
and recipient arteries. Small or fibrotic segments were 
replaced by a segment of arm vein or contralateral 
greater saphenous vein. All operations were per- 
formed by vascular surgeons, vascular fellows, or 
by residents in their last term of surgical training 
supervised by a vascular surgeon. Postoperative anti- 
coagulation with dicoumarol or acenocoumarol was 
instituted postoperatively in all patients who had no 
contraindications to use. 
After discharge a surveillance program, which con- 
sisted of serial colour-flow duplex examinations, and 
ankle blood pressure measurements, commenced. The 
examinations were performed at 6 weeks, 3 months, 6 
months, 9 months, and 12 months after the operation. 
Thereafter ankle blood pressure measurements were 
performed every 6 months. To assess the optimal dur- 
ation of graft surveillance, a regularly measured PSV- 
ratio was used as an indicator of "significant graft sten- 
osis" (PSV-ratio > 2.5). An"event causing stenosis" was 
present if a stenosis required a revision. All revised 
lesions had a diameter eduction greater than 70% on 
angiography. Moreover, stenoses that had caused a 
graft occlusion before a revision was undertaken, were 
defined as "event causing stenoses". A stenosis was 
classified a "de novo stenosis" if the previous PSV-ratio 
was <2.0, and a "progressive stenosis" if it was > 2.0 at 
a previous visit and increased by 1.0 or more. If the graft 
was revised uring follow-up the surveillance schedule 
was resumed as for newly implanted grafts. The duplex 
equipment used was: Acuson 128 XP/10 (Catharina 
Hospital), Hewlett Packard Sonos 1000 (University 
Hospital Maastricht), and Hewlett Packard Sonos 2000 
(Sint Antonius Hospital Nieuwegein). In all three 
centres a 7.5 MHz transducer was applied unless the 
graft was deep, when a 5.0 MHz transducer was used. 
All examinations were performed by qualified tech- 
nologists. The vein graft was examined from the groin 
down its entire length to below the distal anastomosis, 
including the first centimetres of the recipient run-off 
artery. The same surveillance protocol was used in the 
three participating institutions. Adherence to the pro- 
tocol was verified by a visiting data-manager and a 
study nurse. Vascular laboratory meetings were or- 
ganised regularly to ascertain uniform duplex scanning 
techniques and recording of parameters. Intraoperative 
or predischarge duplex entire graft scanning was in- 
frequently performed uring the study. Therefore these 
data were not included in the analysis. Early duplex 
scanning was defined as the first complete graft ex- 
amination, which was at 4-6 weeks postoperatively. 
When surveillance xaminations revealed one of the 
following criteria for an abnormality of the graft, its 
inflow or run-off, a digital subtraction angiography 
was performed: recurrent claudication or rest pain, an 
interval decrease of the ankle brachial index >0.15, a 
peak systolic velocity ratio (PSV-ratio) >2.0, a peak 
systolic velocity at the mid-thigh graft <45 cm/s, and 
end-diastolic velocity >20 cm/s. A PTA or an open 
surgical procedure was only performed if the an- 
giogram confirmed the presence of a stenotic lesion 
with a _> 70% diameter eduction. 
Definitions and data analysis 
A primary event was defined as revision of a stenotic 
but patent graft, or graft occlusion. Primary graft 
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failure was used as the study endpoint for a patient. 
The efficacy of initial surveillance measurements a
predictor for the development of severe graft stenosis 
was represented by the primary patency. For all 
patients the occurrence of primary events and the 
time interval between the event and the initial duplex 
scanning was recorded. Kaplan-Meier curves were 
used with grafts categorised according to the PSV- 
ratio at the first surveillance visit. Receiver operating 
characteristic (ROC) curves were used to assess the 
sensitivity and specificity of the initial PSV-ratio for 
predicting primary graft failure in the first year. The 
analysis was performed using SPSS 7.0 for Windows 
statistical software. 
Results 
Patient series 
Three hundred patients entered the prospective sur- 
veillance program, while 46 patients with infrainguinal 
vein grafts operated on in the same period were not 
considered for analysis, because of death of the patient, 
a reversible graft failure within 30 days after graft 
implantation, or no return for follow-up visits. There 
were 179 (60%) men and 121 (40%) women, with a 
mean age of 70 years (33-99). Operative indications 
for lower limb revascularisation consisted of critical 
ischaemia in 216 (72%) grafts, disabling claudication 
in 78 (26%) and popliteal aneurysm in six (2%) grafts. 
The site of the proximal anastomosis was the common 
femoral artery in 57%, the superficial femoral artery 
in 25% and other sites in 18%. Two hundred and 
sixty-seven (89%) grafts consisted of a single greater 
saphenous vein segment, while composite grafts of 
multiple vein segments were used in 54 (18%). Of the 
latter, 13 (4%) had arm-vein segments used. Other 
graft characteristics and preoperative risk factors are 
summarised in Table 1. Most (74%) of the initial duplex 
examinations were performed within 6 weeks after 
the operation, and 94% were performed within 3 
months after graft implantation. 
Initial duplex examination 
Kaplan-Meier curves of the primary patency were 
constructed for patient groups with an initial PSV- 
ratio <1.5 (group 1), 1.5-2.0 (group 2), 2.0-2.5 (group 
3), 2.5-3.0 (group 4), and >3.0 (group 5) (Fig. 1). Patients 
with "early lesions" groups 2 and 3 did not show a 
Table 1. Risk factors and graft characteristics in 300 infrainguinal 
vein grafts. 
Variables Number of 
grafts (%) 
Presenting symptoms 
Critical imb ischaemia 216 (72) 
Claudication 78 (26) 
Aneurysm 6 (2) 
Associated disease and risk factors 
Diabetes mellitus 117 (39) 
Hypertension 94 (31) 
History of smoking 210 (70) 
History of other vascular disease 152 (51) 
Preoperative data 
ABI ~ <0.60 223 (78) 2 
SVS/ ISCVS 3 run-off score >2.0 178 (59) 
Graft 
Previous ipsilateral infrainguinal 83 (28) 
reconstruction 
Other than in situ graft 172 (57) 
Crural distal anastomosis 150 (50) 
Minimal graft diameter <3.5 mm 38 (13) 
1= ABI, anlde-brachial blood pressure index; 2= incompressible ves- 
sels in 15 patients; 3=Society for Vascular Surgery/International 
Society for Cardiovascular Surgery. 
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_< 1.5 (Group 1) 203 149 95 65 
1.5-2.0 (Group 2) 30 20 11 7 
2.0-2.5 <Group 3) 18 13 7 5 
2.5-3.0 (Group 4) 14 8 3 3 
> 3.0 <Group 5) 35 7 3 1 
Fig. 1. Primary patency rates represented byKaplan-Meier curves 
of patient groups according to the initial PSV-ratio: group 1 (PSV- 
ratio <1.5), group 2 (PSV-ratio 1.5-2.0), group 3 (PSV-ratio 2.0-2.5), 
group 4 (PSV-ratio 2.5-3.0), and group 5 (PSV-ratio >3.0). On the 
abscissa T = 0 represents the time of the initial duplex examination. 
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Fig. 2. Receiver operating characteristic (ROC) curves of the peak 
systolic velocity (PSV-ratio) and its correlation with primary events 
in the first year. 
different course of their primary patency than patients 
with "normal grafts" (group 1) (primary patencies at 
12 months of 63%, 73%, and 71%, respectively). The 
primary patency of groups 4 and 5 at 12 months was 
38% and 21%, respectively. Group 4 differed from 
groups 1 to 3 (p, respectively, <0.001, 0.07, 0.01), and 
group 5 differed from groups 1 to 3 (p, all <0.001). 
The clinical applicability of the initial PSV-ratio to 
discriminate grafts with a high and a low probability 
of encountering a primary event during the first year 
was further assessed by a ROC-analysis, represented 
in Fig. 2. There was no distinct threshold value for 
this separation, as the best combination of sensitivity 
and specificity was still rather low (54% and 75%, 
respectively). The secondary 12-month patency for 
groups with a PSV-ratio > 3.0 and <3.0 was 80% and 
92%, respectively (p = 0.01). 
Duration of surveillance period 
For all grafts in this study (including grafts that were 
enrolled again after their first or second revision) the 
time of onset of "significant stenosis" (PSV-ratio >_2.5), 
and of "event causing de novo stenosis" (revision or 
occlusion) is represented in Table 2. Of all performed 
surveillance xaminations the interval rates of sig- 
nificant de novo stenosis were 17%, 14%, and 10% at 6 
weeks, 3 months, and 6 months. At the ninth and 12th 
month interval the incidence was considerably lower, 
5% and 5%, respectively. Event causing de novo stenosis 
occurred at the sixth week, third month and sixth 
month interval in 8%, 8%, and 8%. At the ninth and 
12th month interval this type of stenosis occurred in 
4% and 7% of the grafts. Of the total of 111 event 
causing stenosis that occurred during the first year, 
100 were associated with a revision and 11 with an 
occlusion. 
In a second analysis of a similar nature, grafts that 
underwent a revision were excluded after this primary 
event. In this assessment, in which second and third 
graft revisions were not considered, the interval rate 
of significant de novo stenosis at 9 and 12 months was 
4% and 3%, respectively, and significant progressive 
stenoses were observed in 2% and 5%, respectively. 
The interval rate of event causing de novo stenosis at 
the ninth and 12th month interval was 2% and 1%, 
respectively (Table 3). Of the total of 82 event causing 
stenoses that were observed in the first year, 75 were 
associated with a revision and seven with an occlusion. 
The sharp drop in the interval incidence of event 
causing de novo stenoses in previously unrevised grafts 
after 6 months is shown in Fig. 3. During the first year, 
of all event causing de novo stenoses, 84% had occurred 
within 6 months. 
Discussion 
The usefulness of duplex scanning for follow-up of 
infrainguinal vein grafts has long been recognised, 
and several comparative studies have demonstrated 
that duplex scanning is superior to standard follow- 
up methods for detecting graft stenosis. 2'I4-17 Some 
individual grafts are at greater risk of failure than 
others. Factors that were reported to be associated 
with this higher risk include: critical limb ischaemia, 
diabetes, poor crural run-off, previous arterial re- 
construction, composite or spliced vein grafts, non-in 
situ technique, and minimal graft diameter. 4'5'1°'16 In the 
present study the risk of severe graft stenosis requiring 
intervention was significantly increased in grafts that 
had a PSV-ratio (>2.5) at the initial duplex ex- 
amination. It is likely that the development of stenoses 
in many patients begins at the time of surgery, and if 
progression is rapid, these lesions are associated with 
a high failure rate. 
It has been suggested that the first duplex scanning 
is best performed at the completion of the operation 
or before discharge. Unrepaired early duplex ab- 
normalities required later correction in 32-52%. ~8'~8 It
is assumed that residual and minor defects in vein 
grafts may serve as a nidus for severe graft stenoses 
to develop later after implantation. It was hypothesised 
that if early postoperative duplex findings permitted 
distinction of grafts into low- and high-risk groups, a 
more rational surveillance protocol may be instituted. 
Mills and coworkers found that 45% of lesions detected 
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Table 2. Stenoses occurring in all grafts surveyed, including grafts that were enrolled 
again after a first and a second revision. 
All grafts 6 3 6 9 12 
weeks months months months months 
Number surveyed grafts 244 244 238 221 210 
Significant graft Total 41 57 50 40 35 
stenosis * De novo 2 41 34 23 11 10 
Progressive 3 - 23 27 29 25 
Event causing Total 20 31 32 12 16 
stenosis 5 De novo 2 20 20 19 8 15 
Progressive - 11 13 4 1 
Recurrent - 4 5 6 9 
stenosis 4 
Event causing de novo stenosis/ 
number grafts (%) 8 8 8 4 7 
l=Significant stenosis: PSV-ratio _>2.5; 2=de novo stenosis: previous PSV-ratio <2.0; 3= 
progressive stenosis: previous PSV-ratio _>2.0 and increase of PSV-ratio _>1.0; 4=recurrent 
stenosis: revised graft with secondary event causing stenosis; S=event causing stenosis: 
graft with revision or occlusion. 
Table 3. Stenoses occurring in surveyed grafts with follow-up ending after a first revision. 
Previously unrevised grafts 6 3 6 9 12 
weeks months months months months 
Number surveyed grafts 244 244 203 169 152 
Significant graft Total 41 50 39 24 18 
stenosis ~ De rlovo 2 41 31 18 6 5 
Progressive sten? - 9 12 4 7 
Stable sten. 4 - 10 9 14 6 
Event causing Total 20 26 23 6 7 
stenosis 5 De novo 20 19 15 4 2 
Progressive - 7 8 2 5 
Event causing de novo stenosis/ 
number grafts (%) 8 8 7 2 1 
~=Significant s enosis: PSV-ratio _>2.5; 2=de rlovo stenosis: previous PSV-ratio <2.0; 3= 
progressive stenosis: previous PSV-ratio _>2.0 and increase of PSV-ratio _>1.0; 4=stable 
stenosis: previous PSV-ratio >2.0 and increase of PSV-ratio <1.0; ~= event causing stenosis: 
graft with revision or occlusion. 
o 
10, 
0LP 
6 weeks 
o-..,, 
r __  J I I_ 
3 6 9 12 months 
Surveillance period 
Fig. 3. The incidence of event causing de novo stenoses per surveillance interval in previously unrevised grafts during the first postoperative 
year. 
by  in t raoperat ive  dup lex  scann ing  progressed  to h igh-  
g rade  stenoses,  wh ich  e i ther  requ i red  rev is ion  or oc- 
c luded  be fore  an in tervent ion  was  per fo rmed.  In  their  
s tudy  23% of les ions remained  stable,  and  32% re- 
gressed.  6 These  authors ,  as we l l  as others ,  suggested  
that  an  ear ly  separat ion  of  grafts  into  h igh- r i sk  and  
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low-risk groups was possible, allowing them to focus 
all surveillance attention to the higher risk group, 
while subjecting the other grafts to a less intensive or 
no-surveillance policy. 6'8 The outcome of the present 
prospective study supports the observation of these 
earlier studies, though not necessarily their con- 
clusions. As expected, we found that early severe 
lesions (PSV-ratio > 2.5) quite often required arevision. 
Grafts with "early mild to moderate lesions" rep- 
resented by initial PSV-ratios between 1.5 and 2.5 
follow a similar course with regard to primary patency 
as grafts in patients with completely normal PSV-ratios 
(<1.5). In addition, it appears that patients with normal 
grafts by no means avoid later trouble, as the primary 
patency at 12 months was 71%. Therefore, excluding 
initially normal grafts from further surveillance would 
have resulted in a less effective surveillance protocol. 
These observations are supported by other studies, in 
which it was found that normal early duplex findings 
did not equate with the long-term absence of graft- 
threatening lesions. I9'2° Consequently, all grafts need 
to be followed from an early stage. At present we 
perform a full predischarge duplex scan in all patients. 
Whether this will improve on the information obtained 
by a 6-week scan as the initial examination requires 
further evaluation. It is known that approximately 
one-third of early identified stenoses regress, 6 negating 
the usefulness of their detection in the first post- 
operative week. The favourable overall outcome of 
revising identified severely stenotic lesions, which has 
been reported in many previous stud ies ,  2'7'17'19 was  
confirmed in the present study. The secondary patency 
rate in the category with PSV-ratios _> 3.0 was 80%, 
which may be considered a satisfactory result. 
Taylor et al. were among the first to propose a 
rationalised surveillance program by limiting the dur- 
ation. 9 In their study all stenoses were detected in the 
first year after operation and none occurred after this 
time. It was recognised that grafts will continue to fail 
in subsequent years, but this was at an annual rate of 
only 2-3%, which did not justify the cost involved 
with continuing surveillance of all grafts. At the pres- 
ent time many authors agree that routine graft sur- 
veillance is not indicated after 12 months of follow- 
up. 4'9'21 However, Erickson et al. maintain an opposite 
view. 13 They observed that, of 236 grafts that developed 
surveillance abnormalities, 21 had their initial defect 
more than 2 years after the initial bypass procedure. 
However, in this series stenoses in the vein itself 
developed after a median follow-up period of 6-8.5 
months, whereas inflow and run-off lesions developed 
after a median follow-up of 15 and 29 months, re- 
spectively. This difference in the time of onset of lesions 
in the vein conduit and in the arteries was explained 
by the different nature of the lesions, with slower 
progressing atherosclerosis being the dominant factor 
in the inflow and run-off segments. 
It has been suggested that grafting technique makes 
a difference to the time of onset of stenoses. In a series 
exclusively consisting of in situ bypasses, only two of 
117 grafts needed a revision after 6 months of follow- 
up.  22 Unfortunately, not many series will exclusively 
consist of in situ bypasses, as this type of bypass 
requires a greater saphenous vein with a good calibre 
throughout i s entire length. We found that grafts with 
treated stenoses are at increased risk of developing a
recurrent stenosis or a second stenosis at another 
location. After revision a venous bypass should be 
followed by regular duplex examination for at least 
another 6 months, as a recurrence can be expected in 
about one out of four grafts. 9'23'24 However, the majority 
of grafts do not require an intervention within 6 
months after operation, and if there is no evidence of 
a stenosis and the maximum PSV-ratio is less than 2.0, 
intensive surveillance can be safely stopped, which 
was the crucial observation i the present study. Only 
2% of surveilled patients without previous revision at 
9 months and in 1% at 12 months developed an event 
causing de novo stenosis. Moreover, it has been reported 
that de novo lesions that develop after 6 months tend 
to be stable, and infrequently require revision. 25'26 
In conclusion, the typical time course of vein-graft 
failure and intervention appeared to be related to the 
onset and progression of graft lesions. Our current 
protocol after discharge includes examinations at 6 
weeks, 3 months and 6 months. Thereafter, in the 
absence of previous revisions or duplex abnormalities, 
discretionary clinical examinations may be scheduled 
annually. 
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